• Home
  • Resume
  • Research & Manuscripts

Research & Manuscripts

You can find the full list of my publications on Google Scholar

Select publications

DateArticle | AuthorsJournal
8/2022 Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients
Ceyhan-Birsoy O, Jayakumaran G, Kemel Y, …, Zehir A, and Mandelker D
Genome Med.
10/2022 Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing
Ptashkin RN, Ewalt MD, Jayakumaran G, …, Zehir A, and Arcila ME
Biorxiv
6/2021 Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
Rose Brannon A, Jayakumaran G, Diosdado M, …, Zehir A, and Benayed R
Nat. Commun.
2/2021 Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
Fiala EM, Jayakumaran G, Mauguen A, …, Zehir A, and Walsh MF
Nature Cancer
10/2021 Clonal hematopoiesis is associated with risk of severe Covid-19
Bolton KL, Koh Y, Foote MB, …, Kim NJ, and Zehir A
Nat. Commun.
9/2020 MiMSI - a deep multiple instance learning framework improves microsatellite instability detection from tumor next-generation sequencing
Ziegler J, Hechtman JF, Ptashkin R, …, Fuchs TJ, and Zehir A
Biorxiv
11/2020 Cancer therapy shapes the fitness landscape of clonal hematopoiesis
Bolton KL, Ptashkin RN, Gao T, …, Zehir A, and Papaemmanuil E
Nat. Genet.
11/2018 Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid Tumors
Ptashkin RN, Mandelker DL, Coombs CC, …, Berger MF, and Zehir A
Jama Oncol
9/2017 Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Coombs CC, Zehir A, Devlin SM, …, Levine RL, and Berger MF
Cell Stem Cell
6/2017 Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Zehir A, Benayed R, Shah RH, …, Ladanyi M, and Berger MF
Nat. Med.
10/2017 Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data
Middha S, Zhang L, Nafa K, …, Zehir A, and Hechtman JF
Jco Precis Oncol
5/2015 Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Cheng DT, Mitchell TN, Zehir A, …, Ladanyi M, and Berger MF
J. Mol. Diagn.